GlassScriptPhysician profile
Charles Douglas Neff
NPI 1053161919
$317.85
in general payments reported to CMS, 2019-2025
8 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $54.43 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $88.79 | 2025 | Afx2 Bifurcated Endograft System |
| Solventum Corporation | $79.95 | 2024-2025 | Prevena, Abthera, V.A.C.Ulta |
| Caris Mpi, INC. | $31.49 | 2025 | Mi Cancer Seek |
| Medtronic, INC. | $29.84 | 2025 | Ligasure |
| Ethicon US, LLC | $28.78 | 2025 | Evarrest, Prolene |
| Abbott Laboratories | $24.29 | 2025 | Esprit |
| Astrazeneca Pharmaceuticals LP | $20.33 | 2024 | Andexxa |
| Terumo Medical Corporation | $14.38 | 2024 | Azur Cx Detachable, Navicross, Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.